Cargando…

The aggressive behaviour of squamous cell carcinoma in epidermolysis bullosa: analysis of clinical outcomes and tumour characteristics in the Dutch EB Registry

Detalles Bibliográficos
Autores principales:	Harrs, Clara, van den Akker, Peter C., Baardman, Rosalie, Duipmans, José C., Horváth, Barbara, van Kester, Marloes S., Lemmink, Henny H., Rácz, Emoke, Bolling, Marieke C., Diercks, Gilles F.H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9805058/ https://www.ncbi.nlm.nih.gov/pubmed/35830206 http://dx.doi.org/10.1111/bjd.21769

Ejemplares similares

Novel insights into the epidemiology of epidermolysis bullosa (EB) from the Dutch EB Registry: EB more common than previously assumed?
por: Baardman, R., et al.
Publicado: (2020)

The importance of accurate epidemiological data of epidermolysis bullosa
por: Baardman, Rosalie, et al.
Publicado: (2022)

Therapeutic Prospects of Exon Skipping for Epidermolysis Bullosa
por: Vermeer, Franciscus C., et al.
Publicado: (2021)

Patients’ and parents’ experiences during wound care of epidermolysis bullosa from a dyadic perspective: a survey study
por: Mauritz, Petra J., et al.
Publicado: (2022)

Cannabinoid use and effects in patients with epidermolysis bullosa: an international cross-sectional survey study
por: Schräder, Nicholas H. B., et al.
Publicado: (2021)

Therapies for epidermolysis bullosa: delivery is key
por: Bremer, J., et al.
Publicado: (2019)

A comparison study of outcome measures for epidermolysis bullosa: Epidermolysis Bullosa Disease Activity and Scarring Index (EBDASI) and the Instrument for Scoring Clinical Outcomes of Research for Epidermolysis Bullosa (iscorEB)
por: Rogers, Clare L., et al.
Publicado: (2021)

The C4EB study—Transvamix (10% THC / 5% CBD) to treat chronic pain in epidermolysis bullosa: A protocol for an explorative randomized, placebo controlled, and double blind intervention crossover study
por: Schräder, Nicholas H. B., et al.
Publicado: (2022)

Natural Exon Skipping Sets the Stage for Exon Skipping as Therapy for Dystrophic Epidermolysis Bullosa
por: Bremer, Jeroen, et al.
Publicado: (2019)

Pan-urethral stricture with epidermolysis bullosa (EB): A case report
por: Sharifian, Rayka, et al.
Publicado: (2021)

Clinical practice guidelines for laboratory diagnosis of epidermolysis bullosa
por: Has, C., et al.
Publicado: (2019)

The relationship between quality of life and coping strategies of children with EB and their parents
por: Mauritz, Petra J., et al.
Publicado: (2021)

Identifying Epidermolysis Bullosa Patient Needs and Perceived Treatment Benefits: An Explorative Study Using the Patient Benefit Index
por: Schräder, Nicholas H. B., et al.
Publicado: (2021)

Immunoglobulin M bullous pemphigoid: An enigma
por: Baardman, Rosalie, et al.
Publicado: (2020)

Combined tetrahydrocannabinol and cannabidiol to treat pain in epidermolysis bullosa: a report of three cases
por: Schräder, N.H.B., et al.
Publicado: (2018)

Topography of Distinct Staphylococcus aureus Types in Chronic Wounds of Patients with Epidermolysis Bullosa
por: van der Kooi-Pol, Magdalena M., et al.
Publicado: (2013)

Progress Towards Treatment and Cure of Epidermolysis Bullosa: Summary of the DEBRA International Research Symposium EB2015
por: Uitto, Jouni, et al.
Publicado: (2016)

Murine type VII collagen distorts outcome in human skin graft mouse model for dystrophic epidermolysis bullosa
por: Bremer, Jeroen, et al.
Publicado: (2018)

Inherited epidermolysis bullosa
por: Fine, Jo-David
Publicado: (2010)

Dystrophic Epidermolysis Bullosa
por: Yadav, Randhir Sagar, et al.
Publicado: (2018)

Epidermolysis bullosa acquisita()
por: Miyamoto, Denise, et al.
Publicado: (2022)

Dystonin modifiers of junctional epidermolysis bullosa and models of epidermolysis bullosa simplex without dystonia musculorum
por: Sproule, Thomas J., et al.
Publicado: (2023)

The quality of life in epidermolysis bullosa (EB-QoL) questionnaire: Translation, cultural adaptation, and validation into the Farsi language
por: Yazdanshenas, Atoosa, et al.
Publicado: (2020)

Epidermolysis bullosa pruriginosa responding to dupilumab
por: Clawson, Rebecca C., et al.
Publicado: (2021)

The risk of cardiomyopathy in inherited epidermolysis bullosa
por: Fine, J-D, et al.
Publicado: (2008)

The Epidermolysis bullosa house in Salzburg
por: Pohla-Gubo, Gabriela
Publicado: (2010)

Pretibial dystrophic epidermolysis bullosa
por: Callegaro, Elisabeth de Albuquerque Cavalcanti, et al.
Publicado: (2017)

Revertant Mosaicism in Epidermolysis Bullosa
por: Meyer-Mueller, Cameron, et al.
Publicado: (2022)

Familial Epidermolysis Bullosa Pruriginosa
por: Trivedi, Madhvi, et al.
Publicado: (2022)

Hyperkeratotic hand eczema: Eczema or not?
por: Politiek, Klaziena, et al.
Publicado: (2020)

Vulvar involvement in epidermolysis bullosa: Case series
por: Dang, Julie, et al.
Publicado: (2021)

Epidermolysis Bullosa Acquisita: A Case Report
por: Kumetz, Erik A., et al.
Publicado: (2020)

A Drosophila model of Epidermolysis Bullosa Simplex
por: Bohnekamp, Jens, et al.
Publicado: (2015)

Issues of management of Epidermolysis bullosa in Georgia
por: Kvlividze, Oleg, et al.
Publicado: (2010)

Dystrophic epidermolysis bullosa in a child
por: Eswara, Uma
Publicado: (2012)

Case of Epidermolysis Bullosa with Pyloric Atresia
por: Kim, Jae-Hong, et al.
Publicado: (2011)

A rare case of epidermolysis bullosa
por: Narendra, S. M., et al.
Publicado: (2013)

Dystrophic epidermolysis bullosa: a review
por: Shinkuma, Satoru
Publicado: (2015)

Anesthetic consideration in dystrophic epidermolysis bullosa
por: Narejo, AS, et al.
Publicado: (2016)

Recently Identified Forms of Epidermolysis Bullosa
por: McGrath, John A.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_pfjkual10lt0ovtcn2b64ejcev